Johnson & Johnson (NYSE: JNJ) agreed to acquire Shockwave Medical Inc. (Nasdaq: SWAV) for about $13.1 billion in enterprise value to bolster its expansion into making medical devices to treat heart disease.
To read the entire story, you must be logged in.
Please log in now or register with us.
